Enovix (ENVX) to Release Quarterly Earnings on Wednesday

Enovix (NASDAQ:ENVX) will likely be announcing its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of ($0.17) per share and revenue of $10.2490 million for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Wednesday, February 25, 2026 at 5:00 PM ET.

Enovix Trading Down 1.3%

Shares of ENVX opened at $5.87 on Tuesday. The company has a debt-to-equity ratio of 1.74, a current ratio of 9.72 and a quick ratio of 9.47. Enovix has a 1-year low of $5.27 and a 1-year high of $16.49. The stock has a market cap of $1.27 billion, a price-to-earnings ratio of -7.25 and a beta of 2.13. The firm has a 50 day simple moving average of $7.24 and a 200-day simple moving average of $9.01.

Wall Street Analyst Weigh In

ENVX has been the subject of several recent research reports. Cantor Fitzgerald dropped their price target on Enovix from $30.00 to $25.00 and set an “overweight” rating for the company in a research report on Thursday, November 6th. Oppenheimer set a $24.00 price objective on Enovix in a research report on Thursday, November 6th. JPMorgan Chase & Co. cut their target price on shares of Enovix from $12.00 to $10.00 and set a “neutral” rating for the company in a research note on Wednesday, November 12th. Canaccord Genuity Group decreased their price target on shares of Enovix from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Thursday, November 6th. Finally, Northland Securities set a $16.00 price target on shares of Enovix in a report on Monday, November 17th. Five analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $17.50.

Hedge Funds Weigh In On Enovix

Large investors have recently bought and sold shares of the stock. Private Advisor Group LLC grew its stake in shares of Enovix by 2.7% during the 3rd quarter. Private Advisor Group LLC now owns 46,519 shares of the company’s stock valued at $464,000 after buying an additional 1,242 shares during the period. Parallel Advisors LLC raised its position in shares of Enovix by 51.9% in the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after buying an additional 1,342 shares during the period. Equitable Holdings Inc. boosted its holdings in Enovix by 10.9% in the third quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock valued at $137,000 after acquiring an additional 1,342 shares during the last quarter. Mariner LLC grew its position in Enovix by 3.4% during the third quarter. Mariner LLC now owns 58,343 shares of the company’s stock valued at $582,000 after acquiring an additional 1,921 shares during the period. Finally, Federation des caisses Desjardins du Quebec increased its stake in Enovix by 2.5% during the fourth quarter. Federation des caisses Desjardins du Quebec now owns 80,853 shares of the company’s stock worth $591,000 after acquiring an additional 1,950 shares during the last quarter. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.